Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclosporin for refractory ulcerative colitis.

Literature DB >> 12524395

Cyclosporin for refractory ulcerative colitis.

C G Loftus¹, E V Loftus, W J Sandborn.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2003 PMID： 12524395 PMCID： PMC1774959 DOI： 10.1136/gut.52.2.172

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

6 in total

Review 1. Cyclosporine in ulcerative colitis: state of the art.

Authors: W J Sandborn
Journal: Acta Gastroenterol Belg Date: 2001 Apr-Jun Impact factor: 1.316

2. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.

Authors: G D'Haens; L Lemmens; K Geboes; L Vandeputte; F Van Acker; L Mortelmans; M Peeters; S Vermeire; F Penninckx; F Nevens; M Hiele; P Rutgeerts
Journal: Gastroenterology Date: 2001-05 Impact factor: 22.682

Review 3. The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

Authors: D W Holt; E A Mueller; J M Kovarik; J B van Bree; K Kutz
Journal: Transplant Proc Date: 1994-10 Impact factor: 1.066

4. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.

Authors: Gert Van Assche; Geert D'Haens; Maja Noman; Séverine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
Journal: Gastroenterology Date: 2003-10 Impact factor: 22.682

5. Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Authors: S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer
Journal: N Engl J Med Date: 1994-06-30 Impact factor: 91.245

6. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors: P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal: N Engl J Med Date: 1987-10-01 Impact factor: 91.245

6 in total

11 in total

1. Refractory ulcerative colitis treatment.

Authors: Richard P Macdermott; Jesse A Green
Journal: Gastroenterol Hepatol (N Y) Date: 2007-01

2. Management of severe ulcerative colitis.

Authors: Neeraj Narula; Bindia Jharap; Jean-Frederic Colombel
Journal: Curr Treat Options Gastroenterol Date: 2015-03

3. Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis.

Authors: Stefan Farkas; Matthias Hornung; Christine Sattler; Markus Guba; Markus Steinbauer; Matthias Anthuber; Hans Herfarth; Hans J Schlitt; Edward K Geissler
Journal: Int J Colorectal Dis Date: 2005-10-14 Impact factor: 2.571

4. Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?

Authors: Edith Y Ho; Fabio Cominelli; Jeffry Katz
Journal: Curr Treat Options Gastroenterol Date: 2015-03

5. Long-term outcome of cyclosporin rescue therapy in acute, steroid-refractory severe ulcerative colitis.

Authors: Tamás Molnár; Klaudia Farkas; Zoltán Szepes; Ferenc Nagy; Mónika Szűcs; Tibor Nyári; Anita Bálint; Tibor Wittmann
Journal: United European Gastroenterol J Date: 2014-04 Impact factor: 4.623

6. Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.

Authors: Stephen J Halpin; P John Hamlin; Daniel P Greer; Lisa Warren; Alexander C Ford
Journal: World J Gastroenterol Date: 2013-02-21 Impact factor: 5.742

7. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.

Authors: I Ordás; E Domènech; M Mañosa; V García-Sánchez; E Iglesias-Flores; M Peñalva; A Cañas-Ventura; O Merino; F Fernández-Bañares; F Gomollón; M Vera; A Gutiérrez; E Garcia-Planella; M Chaparro; M Aguas; E Gento; F Muñoz; M Aguirresarobe; C Muñoz; L Fernández; X Calvet; C E Jiménez; M A Montoro; A Mir; M L De Castro; M F García-Sepulcre; F Bermejo; J Panés; M Esteve
Journal: Am J Gastroenterol Date: 2017-07-04 Impact factor: 10.864